[Use of a prostaglandin derivative in the treatment of gastroduodenal ulcer and gastroduodenitis].
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D004381:Duodenal Ulcer / Q000188:drug therapy*; D004382:Duodenitis / Q000188:drug therapy*; D004384:Duodenoscopy; D005227:Fatty Acids / Q000627:therapeutic use*; D005756:Gastritis / Q000188:drug therapy*; D005773:Gastroscopy; D006801:Humans; D011466:Prostanoic Acids / Q000627:therapeutic use*; D011899:Ranitidine / Q000627:therapeutic use; D013276:Stomach Ulcer / Q000188:drug therapy*
D000897:Anti-Ulcer Agents; D005227:Fatty Acids; D011466:Prostanoic Acids; D011899:Ranitidine; C035288:rosaprostol
L'impiego di un derivato prostaglandinico nel trattamento dell'ulcera gastroduodenale e delle gastroduodeniti.